Chimeric antigen receptors targeting g-protein coupled receptor and uses thereof
US-2024294599-A1 · Sep 5, 2024 · US
US9404097B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9404097-B2 |
| Application number | US-201214348322-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 2, 2012 |
| Priority date | Sep 30, 2011 |
| Publication date | Aug 2, 2016 |
| Grant date | Aug 2, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A peptide for synthesizing silica and use thereof are provided. The peptide for synthesizing silica can polymerize silica from a silica precursor in an aqueous solution having conditions of normal temperature, normal pressure and near-neutral weak base. The peptide for synthesizing silica can form a self-assembled structure during silica synthesis, and thus can be used as various biomaterials such as a silica-based protein immobilizer, a biosensor, and a drug delivery system.
Opening claim text (preview).
What is claimed is: 1. A method of synthesizing silica, comprising: reacting a silica precursor with at least one peptide, wherein said peptide is selected from the group consisting of amino acid sequences set forth in SEQ ID NOs: 1 to 7, and a fusion protein thereof, wherein said fusion protein comprises a self-assembling protein and at least one peptide selected from the group consisting of amino acid sequences set forth in SEQ ID Nos: 1 to 7. 2. The method of claim 1 , wherein the reacting is performed in an aqueous solution of pH 6 to 8 under conditions of normal temperature and a normal pressure. 3. The method of claim 1 , wherein the reacting is performed in the aqueous solution further comprising an enzyme or a binding peptide, wherein the binding peptide is at least one selected from the group consisting of an antibody, a peptide specifically binding to DNA or RNA, or a receptor. 4. The method of claim 1 , wherein the reacting is performed in the aqueous solution further comprising a nanotube or a nanomesh. 5. The method of claim 1 , wherein the reacting is performed in the aqueous solution further comprising a phospholipid. 6. The method of claim 1 or 5 , wherein the reacting is performed for preparing a single silica film by allowing at least one peptide selected from the group consisting of amino acid sequences set forth in SEQ ID NOs: 1 to 7, a silica precursor and a phospholipid to react with each other, or synthesizing a porous silica by allowing the peptide, the silica precursor and the phospholipid to react with each other to prepare an organic/inorganic complex, and treating the organic/inorganic complex with heat or an organic solvent to remove an organic substance. 7. The method of claim 1 , wherein the reacting is performed in the aqueous solution further comprising hydroxyapatite.
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof · CPC title
Preparations for testing in vivo · CPC title
Phosphotransferases with an alcohol group as acceptor (2.7.1) · CPC title
Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases · CPC title
Peptides being immobilised on, or in, an inorganic carrier · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.